Webform

Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name

Triplet Does Not Improve Survival in Prostate Cancer

Adding Xtandi to Zytiga and prednisone did not improve progression-free survival for patients with metastatic castration-resistant prostate cancer, according to a recent study. Read more.


Source: CURE Magazine

Share